References
- 1
Stange J, Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R.
A new procedure for the removal of protein bound drugs and toxins.
ASAIO Journal.
(1993);
39
M621-M625
- 2
Stange J, Mitzner S R, Risler T, Erley C M, Lauchart W, Goehl H, Klammt S, Peszynski P,
Freytag J, Hickstein H, Löhr M, Liebe S, Schareck W, Hopt U T, Schmidt R.
Molecular Adsorbent Recirculating System (MARS): Clinical results of a new membrane-based
blood purification system for bioartificial liver support.
Artificial Organs.
(1999);
23
319-330
- 3 Gross G W. Internal dynamics of randomized mammalian neuronal networks in culture. Stenger
DA and McKenna TM Enabling Technologies for Cultured Neural Networks Academic Press,
New York 1994: pp 277-317.
- 4
Gross G W, Norton S, Gopal K, Schiffmann D, Gramowski A :.
Neuronal networks in vitro: Applications to neurotoxicology, drug development, and
biosensors.
Biosensors and Bioelectronics.
(1997);
10
553-567
- 5
Butterworth R F.
Complications of cirrhosis III. Hepatic encephalopathy.
J. Hepatol.
(2000);
32 (1 Suppl)
171-180
- 6 Plum F. Handbook of Clinical Neurology. Vinken PJ New York; American Elsevier 1969
Vol. 27: 349-377.
- 7
Hazell A S, Butterworth R F.
Hepatic encephalopathy: an update of pathophysiologic mechanisms.
Proc. Soc. Exp. Biol. Med.
(1999);
222
99-112
- 8
Albrecht J, Jones E A.
Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.
J. Neurol. Sci.
(1999);
170
138-146
- 9
Jones E A, Basile A S.
Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure?.
Metab. Brain Dis.
(1998);
13
351-360
Jan Loock
Department of Internal Medicine University of Rostock, Germany
Email: Jloock@freenet.de
